Approach 2 [„Multiple Recordings“] | ||||
---|---|---|---|---|
Mean [%/months] | SD [%/months] | Range [%/months] | P-value | |
subset B (carcinoma group) | ||||
female (n = 22) | 10.7 | 29.1 | −1.6 - 142.4 | 0.117 |
male (n = 4) | 4.9 | 2.3 | 2.0–7.3 | |
age < 50 years (n = 14) | 19.3 | 39.1 | −1.6 - 142.4 | 0.361 |
age ≥ 50 years (n = 12) | 1.8 | 2.1 | −2.0 - 7.3 | |
us type 2 or 3 (n = 7) | 2.2 | 2.5 | −1.5 - 7.3 | 0.57 |
us type 4 or 5 (n = 21) | 8.1 | 24.8 | −1.6 - 142.4 | |
subset C (adenoma group) | ||||
female (n = 22) | 1.8 | 4.0 | −8.3 - 19.3 | 0.337 |
male (n = 4) | 4.5 | 7.0 | −0.3 - 18.2 | |
vage <50 years (n = 12) | 2.3 | 4.1 | −1.6 - 19.3 | 0.960 |
age ≥ 50 years (n = 14) | 1.7 | 3.9 | −8.3 -18.2 | |
us type 2 or 3 (n = 18) | 2.1 | 4.2 | −8.3 - 19.3 | 0.088 |
us type 4 or 5 (n = 8) | 1.8 | 4.0 | −2.0 - 18.2 |